KELIM 评分可预测铂耐药 / 难治性复发性卵巢癌患者的预后。
关键词: CA-125 KELIM ovarian cancer primary chemosensitivity prognostic biomarker
Mesh : Humans Female Ovarian Neoplasms / drug therapy Drug Resistance, Neoplasm / drug effects Neoplasm Recurrence, Local Platinum / therapeutic use Prognosis Middle Aged Treatment Outcome
来 源:
DOI:10.1080/17520363.2024.2352409
PDF(Pubmed)